SLC5A2 and dementia: Furthermore, diabetic patients treated with SGLT2 inhibitors had a lower rate of diabetic complications as well as a lower risk of development of dementia compared with patients using other groups of anti-diabetic drugs (Siao et al. 2022; Mui et al. 2021).